Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Net Cash Flow (2017 - 2020)

enVVeno Medical has reported Net Cash Flow over the past 4 years, most recently at $3.7 million for Q4 2020.

  • Quarterly results put Net Cash Flow at $3.7 million for Q4 2020, up 326.48% from a year ago — trailing twelve months through Dec 2020 was $7.2 million (up 1257.81% YoY), and the annual figure for FY2025 was $1.3 million, up 170.26%.
  • Net Cash Flow for Q4 2020 was $3.7 million at enVVeno Medical, up from $3.3 million in the prior quarter.
  • Over the last five years, Net Cash Flow for NVNO hit a ceiling of $5.6 million in Q2 2018 and a floor of -$1.7 million in Q3 2018.
  • Median Net Cash Flow over the past 4 years was $263504.0 (2017), compared with a mean of $666213.4.
  • Biggest five-year swings in Net Cash Flow: crashed 690.27% in 2018 and later soared 326.48% in 2020.
  • enVVeno Medical's Net Cash Flow stood at -$233795.0 in 2017, then tumbled by 519.69% to -$1.4 million in 2018, then fell by 12.93% to -$1.6 million in 2019, then soared by 326.48% to $3.7 million in 2020.
  • The last three reported values for Net Cash Flow were $3.7 million (Q4 2020), $3.3 million (Q3 2020), and $843795.0 (Q2 2020) per Business Quant data.